Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
2.78
0.28 (11.20%)
At close: Jun 24, 2025, 3:59 PM
2.75
-1.08%
After-hours: Jun 24, 2025, 04:05 PM EDT
11.20% (1D)
Bid | 2.03 |
Market Cap | 4.15M |
Revenue (ttm) | 11.59M |
Net Income (ttm) | -5.08M |
EPS (ttm) | -1.23 |
PE Ratio (ttm) | -2.26 |
Forward PE | 1.8 |
Analyst | n/a |
Ask | 2.76 |
Volume | 22,197 |
Avg. Volume (20D) | 16,601 |
Open | 2.55 |
Previous Close | 2.50 |
Day's Range | 2.54 - 2.84 |
52-Week Range | 1.94 - 12.32 |
Beta | 0.03 |
About EVOK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVOK
Website n/a
6 months ago
+24.77%
Evoke Pharma shares are trading higher after the c...
Unlock content with
Pro Subscription
7 months ago
+33.58%
Evoke Pharma shares are trading higher after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.

3 months ago · proactiveinvestors.co.uk
William Hill owner Evoke falls at the first-quarter updateEvoke PLC (LSE:EVOK) shares plummeted 18% after the William Hill owner reported annual results in line with expectations but revealed slower growth at the start of 2025. Results for the past calendar...